EP 0785786 A1 19970730 - MICROBIAL SYNTHESIS OF HIV PROTEASE INHIBITORS
Title (en)
MICROBIAL SYNTHESIS OF HIV PROTEASE INHIBITORS
Title (de)
MIKROBIELLE SYNTHESE VON HIV-PROTEASEHEMMER
Title (fr)
SYNTHESE MICROBIENNE D'INHIBITEURS DE LA PROTEASE DU VIH
Publication
Application
Priority
- US 9513628 W 19951020
- US 32863494 A 19941025
Abstract (en)
[origin: WO9612492A1] Biotransformation products of a fermentation with culture MA7065 are potent HIV protease inhibitors. These products are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
IPC 1-7
IPC 8 full level
C12P 17/16 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61P 31/12 (2006.01); A61P 37/04 (2006.01); C07D 241/04 (2006.01); C07D 241/24 (2006.01); C07D 401/06 (2006.01); C07D 413/06 (2006.01); C12N 1/20 (2006.01); C12N 7/00 (2006.01); C12R 1/465 (2006.01)
CPC (source: EP)
A61K 31/496 (2013.01); A61K 31/70 (2013.01); A61P 31/12 (2017.12); A61P 37/04 (2017.12); C07D 241/04 (2013.01); C07D 241/24 (2013.01); C07D 401/06 (2013.01); C07D 413/06 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9612492 A1 19960502; AU 3966395 A 19960515; AU 702122 B2 19990211; EP 0785786 A1 19970730; EP 0785786 A4 19980128; JP H10507917 A 19980804
DOCDB simple family (application)
US 9513628 W 19951020; AU 3966395 A 19951020; EP 95937602 A 19951020; JP 51408295 A 19951020